31st Sea Games - Vietnam 2021 Covid-19 Pandemic
Home / Health & Education / Health
Three drugs with molnupiravir are licensed to treat Covid-19 patients
Anh Kiet 15:07, 2022/01/08
Molnupiravir has been used globally to treat mild and asymptomatic Covid-19 patients.

The Advisory Council for the Registration of Drugs and Medicinal Ingredients Circulation under the Ministry of Health (MoH) has just agreed to a proposal to grant licenses for conditional circulation of three indigenous drugs containing molnupiravir to treat Covid-19 patients.

The MoH said that the council made the decision after making thorough and careful consideration of opinions from specialized units and experts.

 Molnupiravir drugs. Photo: MoH

The council requested manufacturers to examine material quality before production, strictly monitor the drug quality on a monthly basis and send reports to relevant authorities.

In terms of the authorization for Covid-19 drug circulation, the MoH asked regulators and specialized agencies to strictly control quality and prices in line with the Law on Pharmacy and to fight against group interest in medicine supply.

Molnupiravir has been used globally to treat mild and asymptomatic Covid-19 patients.

The medication has proved to be safe and effective in reducing the risk of hospitalization and death among mild to moderate patients who are at increased risk of developing severe symptoms.

Besides, molnupiravir has obvious effectiveness in reducing viral load, virus spread and the number of severe cases, as well as shortening treatment time, with no fatalities recorded.

Vietnam has been trialing the use of a molnupiravir drug made by the US-based pharmaceutical companies Ridgeback Biotherapeutics and Merck & Co to treat Covid-19 patients with mild symptoms since last year. It is distributed for free under special supervision.

Since mid August, the MoH has implemented a pilot plan to administer molnupiravir to mild and asymptomatic cases at home.

The plan was first carried out in Ho Chi Minh City and has so far been replicated in 51 other cities and provinces, with 300,000 doses provided. However, the MoH has yet to issue a license for the drug commercial use till now.

RELATED NEWS
TAG: Three drugs with molnupiravir licensed to treat Covid-19 patients
Other news
10:34, 2023/34/25
A Hanoi elite citizen with 24 years caring for people’s health
The Hanoi elite citizen is not only known as a front-line health worker against the Covid-19 pandemic but a "hero" with a compassionate heart for HIV/AIDS patients.
18:13, 2023/13/23
Vietnam shows leading role in regional health services: US CDC
Vietnam’s active role in ASEAN and its longstanding relationship in health with US CDC and neighborhood partners reinforce its position as the leading contributor to regional public health services.
21:19, 2023/19/05
Vietnam strengthens supervision at border gates to monitor new Covid-19 variants
Vietnam has asked border areas to speed up the vaccination campaigns and complete the job in the first two weeks of January.
13:36, 2022/36/26
US, Vietnam can rely on each other: CDC
The long-lasting and intensified partnership has enabled both sides to advance the collaboration, highlighting improving Vietnam’s medical systems and improving universal healthcare.
22:43, 2022/43/23
Hanoi to ensure of Covid-19 vaccination course for children aged 5-11
The request is made as only 60% of the city's 5-11 years old fully vaccinated.
12:26, 2022/26/10
Hanoi to ensure medicine supply during Tet holiday
Hospitals and a disease control center in Hanoi are tasked with building their own plans to stock up on medicines.